<< Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101 | HHS Secretary issues statement after receiving letter from WellPoint >>
Read in | English | Português | עִבְרִית | Bahasa | Svenska

Anti-PC antibody linked to reduced risk of arteriosclerosis

Published on February 12, 2010 at 5:33 AM · 1 Comment

The chances of suffering a stroke are linked to the presence of a certain type of antibody in the immune system, a new study from Karolinska Institutet shows. The researchers hope to be able to develop a vaccine that can mobilise the body's own defence against arteriosclerosis and stroke.

The research group, which was led by Professor Johan Frostegård, has previously demonstrated that high levels of a certain type of antibody (anti-PC) in the immune defence are linked to a reduced risk of arteriosclerosis, a common cause of thrombosis and myocardial infarction.

In the present study, the researchers focused exclusively on stroke - a blood clot in the brain - and compared 227 individuals who had suffered stroke over a 13-year period with 445 sex and age-matched controls. After controlling for other risk factors (age, sex, smoking habits, cholesterol levels, diabetes, BMI and blood pressure), they were able to show that low levels (below 30 per cent of average) of PC antibodies correlated with a higher risk of stroke, which in women meant an almost three-fold increase.

The researchers have now advanced the hypothesis that low levels of natural PC antibodies, which can be a condition of a poor immune system - contribute to the development of arteriosclerosis and its consequences, which include stroke.

"We're now examining the possibility of developing new immunological treatments for arteriosclerosis and stroke, either in the form of a vaccine to stimulate the immune defence or immunisation through the injection of antibodies," says Professor Frostegård.

Arteriosclerosis is formed by the accumulation of plaque on the walls of blood vessels, which can rupture and form a blood clot. The researchers believe that the PC antibodies react to a substance called phosphorylcholine (PC), which is a component of a class of fat molecules (phospholipids) that go to make up the plaque.

http://ki.se

Comments
  1. sjgreen sjgreen United States says:

    Similiar to anti-PC, anti-cholesterol antibodies have been shown to exhibit a similar cardioprotective effective.

    A number of independent reports over the past decade have correlated high levels of anti-cholesterol antibodies with a significant reduction of both diet-induced hypercholesterolemia and atherosclerotic lesions. Humans with peripheral atherosclerosis and cerebrovascular disease reportedly have low levels of circulating cholesterol antibodies.

    Like anti-PC, naturally-occurring anti-cholesterol antibodies may serve an immuno-housekeeping or protective role by facilitating the clearance of oxidized cholesterol-rich particles in both the blood stream and in the gut.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading